After an in vitro enzyme binding assay reported earlier, the authors evaluated the potency of the selected remedy extracts and active ingredients, including glabridin, in the cellular anti-tyrosinase model using murine melanoma (B16F1) cells. Here, TYR is linked to melanoma.